Cyproheptadine in the control of Cushing's disease

Johns Hopkins Med J. 1981 Aug;149(2):77-83.

Abstract

A patient with Cushing's disease was treated with cyproheptadine with concomitant remission of the disease for 60 months. Despite clinical improvement and achievement of normal levels of cortisol excretions, her menstruation-related cyclic surge of cortisol secretion was supranormal. The mode of action of cyproheptadine was studied by the administration of metyrapone. Long-term administration of cyproheptadine appeared to normalize excessive adrenocorticotropic hormone (ACTH) production by reducing the frequency and the peak levels of episodic secretion of ACTH.

Publication types

  • Case Reports

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Adult
  • Cushing Syndrome / drug therapy*
  • Cyproheptadine / therapeutic use*
  • Female
  • Humans
  • Hydrocortisone / urine
  • Metyrapone

Substances

  • Cyproheptadine
  • Adrenocorticotropic Hormone
  • Hydrocortisone
  • Metyrapone